Daiichi Asks Justices To Settle Fight Over Disclaimed Drug IP
Daiichi Sankyo Inc. has asked the U.S. Supreme Court to intervene in a drug patent infringement lawsuit over Apotex Inc.'s campaign to end Mylan Pharmaceuticals Inc.'s generic exclusivity for Benicar through...To view the full article, register now.
Already a subscriber? Click here to view full article